Microsoft surges as OpenAI founder Sam Altman joins tech giant to lead AI effort

Updated at 6:06 AM EST Microsoft (MSFT) - Get Free Report shares powered higher Monday after it said OpenAI founder Sam Altman would lead the tech giant's AI effort following a weekend of boardroom drama that threatened the future of the ChatGPT creator. Microsoft said Altman, as well as his close associate Greg Brockman, will lead a newly-created AI team within the group following the ouster of Altman, and the resignation of Brockman, from OpenAI late Friday. Several key OpenAI employees also threatened to quit the group, which is credited for firing the starting gun on this year's AI investment rush, after a poorly-articulated statement from the board added to the uncertainty tied to Altman's surprise departure. Microsoft CEO Satya Nadella, who lobbied for Altman's return to the helm of OpenAI in the chaotic aftermath of his ousting late Friday, said the tech giant would continue working closely with the ChatGPT creator and its new CEO, former Amazon (AMZN) - Get Free Report Twitch executive Emmett Shear, in the weeks and months ahead. first and last time i ever wear one of these pic.twitter.com/u3iKwyWj0a— Sam Altman (@sama) November 19, 2023 "We remain committed to our partnership with OpenAI and have confidence in our product roadmap, our ability to continue to innovate with everything we announced at Microsoft Ignite, and in continuing to support our customers and partners," Nadella wrote in a post on the X social media website. "We look forward to getting to know Emmett Shear and OAI's new leadership team and working with them. And we’re extremely excited to share the news that Sam Altman and Greg Brockman, together with colleagues, will be joining Microsoft to lead a new advanced AI research team," he added. "We look forward to moving quickly to provide them with the resources needed for their success." Microsoft shares were marked 1.4% higher in pre-market trading to indicate a Monday opening bell price of $375.01 each, a move that would value the Redmond, Washington-based group at around $2.8 trillion. "The train wreck situation at OpenAI created by a four-person board (excluding Altman and Brockman) might go down in tech history as the one of the biggest debacle decisions in the history of Silicon Valley," said Wedbush analyst Dan Ives. Microsoft stock has added more than $1 trillion to its market value so far this year, and alongside Nvidia (NVDA) - Get Free Report, has become one of the hottest tech names in the market, since unveiling a $10 billion investment in OpenAI, the maker of the AI-powered ChatGPT search engine tool, in early January. Microsoft's overall investment of $13 billion, which translates to an equity stake of around 49% in OpenAI, did not come with a board seat. OpenAI's value was last estimated at around $86 billion. The group has touted the potential of ChatGPT, a tool that uses human language to process instructions and which is being embedded in the tech group's also-ran search engine Bing, to close the gap on market leader Google, the eponymous lead product of parent company Alphabet (GOOGL) - Get Free Report. Investors are betting that AI adoption will help Microsoft -- which generated just $3.2 billion in search revenue last year -- challenge the market dominance of Google, which churned around $43 billion.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...

*Подошвы кроссовок*

Фитнес, бег, командные виды спорта, паркур, занятия в зале и на улице требуют определенного типа подошвы спортивной обуви. Например, баскетбольные кроссовки для улицы имеют протектор в виде елочки , иначе игрок будет ...via forma full 5 https://ift.tt/x2XcPMn Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3580841.html)

Подошвы кроссовок

Фитнес, бег, командные виды спорта, паркур, занятия в зале и на улице требуют определенного типа подошвы спортивной обуви. Например, баскетбольные кроссовки для улицы имеют протектор в виде елочки , иначе игрок будет ...via forma full 5 https://ift.tt/x2XcPMn Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Сравнение*

На изображении представлены два пехотинца Красной армии: красноармеец кадровой армии на 22 июня 1941 года и сержант-победитель на 9 мая 1945 года.via forma full 5 https://ift.tt/eVoXyam Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3585532.html)

Сравнение

На изображении представлены два пехотинца Красной армии: красноармеец кадровой армии на 22 июня 1941 года и сержант-победитель на 9 мая 1945 года.via forma full 5 https://ift.tt/eVoXyam Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Форма и камуфляж*

До 2008 года снаряжение спецназа ВС и не относящихся к вооруженным силам ведомств было практически идентичным. Мало того, форма охранника почти полностью копировала обмундирование элитных подразделений, участвующих ...via forma full 5 https://ift.tt/bw2YCIy Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3579766.html)

Форма и камуфляж

До 2008 года снаряжение спецназа ВС и не относящихся к вооруженным силам ведомств было практически идентичным. Мало того, форма охранника почти полностью копировала обмундирование элитных подразделений, участвующих ...via forma full 5 https://ift.tt/bw2YCIy Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug*

Bristol Myers Squibb (BMY) - Get Free Report shares slumped lower in early Monday trading after drugmaker Bayer AG halted late-stage trials of a blood thinning drug that could complicate the development of similar treatments. Bayer shares plunged to a multi-decade low in European trading following a late Sunday update that said its experimental anticoagulant, known as asundexian, was shown to be inferior to Eliquis, a blood-thinner made by Bristol Myers and Pfizer (PFE) - Get Free Report. "This decision is based on the recommendation of the study’s Independent Data Monitoring Committee (IDMC) as part of ongoing surveillance which showed an inferior efficacy of asundexian versus the control arm," Bayer said in a statement. "Although the results from this analysis do not support the continuation of the study, we will continue investigating asundexian and are currently reevaluating other indications in patients in need of antithrombotic treatment," Bayer added. The scrapping of the study, however, has cast doubt on an upcoming 'phase 3' trial of milvexian, a similar 'FIX(a)' inhibitor developed by Bristol Myers and Janssen Pharmaceuticals, a division of Johnson & Johnson (JNJ) - Get Free Report, that will assess its ability to treat patients with various cardio vascular diseases who are at risk to excessive bleeding. The trial, known as Librexia, was granted fast-track approval by the U.S. Food & Drug Administration earlier this year. Bristol Myers had indicated that milvexian could ultimate generate around $5 billion in annual revenues, split with Johnson & Johnson, should it ultimately be approved. Bristol Myers shares were marked 3.6% lower in pre-market trading to indicate an opening bell price of $49.02 each, a move that would still leave the stock with a 25.3% gain over the past six months. Johnson & Johnson shares were marked 0.9% lower at $148.49 each. Bayer shares, meanwhile, were marked 18.8% lower in mid-day Frankfurt trading to change hands at €33.60 each, the lowest levels in more than twelve years.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stocks/bristol-myers-slumps-as-bayer-trial-failure-casts-doubt-on-5-billion-drug)

Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug

Bristol Myers Squibb (BMY) - Get Free Report shares slumped lower in early Monday trading after drugmaker Bayer AG halted late-stage trials of a blood thinning drug that could complicate the development of similar treatments. Bayer shares plunged to a multi-decade low in European trading following a late Sunday update that said its experimental anticoagulant, known as asundexian, was shown to be inferior to Eliquis, a blood-thinner made by Bristol Myers and Pfizer (PFE) - Get Free Report. "This decision is based on the recommendation of the study’s Independent Data Monitoring Committee (IDMC) as part of ongoing surveillance which showed an inferior efficacy of asundexian versus the control arm," Bayer said in a statement. "Although the results from this analysis do not support the continuation of the study, we will continue investigating asundexian and are currently reevaluating other indications in patients in need of antithrombotic treatment," Bayer added. The scrapping of the study, however, has cast doubt on an upcoming 'phase 3' trial of milvexian, a similar 'FIX(a)' inhibitor developed by Bristol Myers and Janssen Pharmaceuticals, a division of Johnson & Johnson (JNJ) - Get Free Report, that will assess its ability to treat patients with various cardio vascular diseases who are at risk to excessive bleeding. The trial, known as Librexia, was granted fast-track approval by the U.S. Food & Drug Administration earlier this year. Bristol Myers had indicated that milvexian could ultimate generate around $5 billion in annual revenues, split with Johnson & Johnson, should it ultimately be approved. Bristol Myers shares were marked 3.6% lower in pre-market trading to indicate an opening bell price of $49.02 each, a move that would still leave the stock with a 25.3% gain over the past six months. Johnson & Johnson shares were marked 0.9% lower at $148.49 each. Bayer shares, meanwhile, were marked 18.8% lower in mid-day Frankfurt trading to change hands at €33.60 each, the lowest levels in more than twelve years.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...

*Казачьи чины*

Казачьи чины — это чины (звания), персонально присваиваемые военнослужащим и военнообязанным (в том числе казакам на льготе)...via forma full 5 https://ift.tt/ElPQv0f Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3584268.html)

Казачьи чины

Казачьи чины — это чины (звания), персонально присваиваемые военнослужащим и военнообязанным (в том числе казакам на льготе)...via forma full 5 https://ift.tt/ElPQv0f Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Stock Market Today: Stocks pause November rally, surging Microsoft supports tech*

Check back here all day with live updates. U.S. equity futures turned lower Monday, while the dollar extended declines against its global peers and Treasury yields steadied, as investors looked to protect a solid November rally amid a light calendar of events in the holiday-shortened week. Updated 6:58 AM EST Microsoft (MSFT) - Get Free Report shares are a key early-mover Monday after it said OpenAI founder Sam Altman, who was ousted by the board of the ChatGPT creator late Friday, will join the tech giant and lead its AI effort. Microsoft shares were marked 2% higher as the most active stock in pre-market trading to indicate an opening bell price of $377.03 each, a fresh all-time high that would value it at around $2.8 trillion.Related: Microsoft surges as OpenAI founder Sam Altman joins tech giant to lead AI effort Stocks notched their third consecutive weekly gain Friday, the longest winning streak since July, taking the S&P 500 to a searing November gain of 7.64% and putting the benchmark less than 2% from the 52-week highs it reached earlier this summer. The Treasury yield pullback that has triggered the remarkable November rally, however, has been stuck in neutral for the past few sessions, and could turn sharply if today's 20-year bond auction sees a slump in foreign demand of a big decline in domestic participation. The Treasury will publish the results at around 1:00 pm Eastern time. Benchmark 10-year notes yields were last seen trading at 4.482% heading into the early New York session, while 2-year notes held at 4.901% following Friday's better-than-expected October housing data.Related: Wall Street cheers lower inflation, but a new risk has investors on edge The larger moves overnight, however, were in the U.S. dollar, which fell to a fresh two-month low of 103.478 against a basket of its global peers before steadying at 103.588, well below its 200-day moving average, as investors continue to discount any Federal Reserve rate hikes while pricing in cuts for as early as May. Investors will likely focus on language from the Fed's November policy decision, which held rates steady for a second consecutive month at between 5.25% and 5.5%, when minutes of the two-day meeting are released Wednesday, for indications as to how policymakers are viewing the central bank's rate path. A smattering of earnings over the next three days, including a third quarter update from Nvidia (NVDA) - Get Free Report after the close of trading on Tuesday, will also keep Wall Street focused ahead of Thursday's market holiday and the traditionally thin liquidity of Black Friday. Heading into the start of the trading day, futures contracts tied to the S&P 500 are indicating a modest 2 point dip while those linked to the Dow Jones Industrial Average are priced for a 31 point gain. The tech-focused Nasdaq, which is up 9.92% for the month, is set for a 2 point bump. In overseas markets, Europe's Stoxx 600 was little-changed in early Frankfurt trading, with drugmaker Bayer AG plunging 20% to a new multi-decade low following the cancellation of late-stage trials of its blood-thinning treatment. Overnight in Asia, Japan's Nikkei 225 touched a fresh 33-year intra-day high of 33,853.46 points before profit taking pushed the benchmark 0.59% lower in the session, while the region-wide MSCI ex-Japan index was marked 0.91% higher into the close of trading.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stocks/stock-market-today-stocks-add-to-november-rally-as-dollar-slides-tech-gains)

Stock Market Today: Stocks pause November rally, surging Microsoft supports tech

Check back here all day with live updates. U.S. equity futures turned lower Monday, while the dollar extended declines against its global peers and Treasury yields steadied, as investors looked to protect a solid November rally amid a light calendar of events in the holiday-shortened week. Updated 6:58 AM EST Microsoft (MSFT) - Get Free Report shares are a key early-mover Monday after it said OpenAI founder Sam Altman, who was ousted by the board of the ChatGPT creator late Friday, will join the tech giant and lead its AI effort. Microsoft shares were marked 2% higher as the most active stock in pre-market trading to indicate an opening bell price of $377.03 each, a fresh all-time high that would value it at around $2.8 trillion.Related: Microsoft surges as OpenAI founder Sam Altman joins tech giant to lead AI effort Stocks notched their third consecutive weekly gain Friday, the longest winning streak since July, taking the S&P 500 to a searing November gain of 7.64% and putting the benchmark less than 2% from the 52-week highs it reached earlier this summer. The Treasury yield pullback that has triggered the remarkable November rally, however, has been stuck in neutral for the past few sessions, and could turn sharply if today's 20-year bond auction sees a slump in foreign demand of a big decline in domestic participation. The Treasury will publish the results at around 1:00 pm Eastern time. Benchmark 10-year notes yields were last seen trading at 4.482% heading into the early New York session, while 2-year notes held at 4.901% following Friday's better-than-expected October housing data.Related: Wall Street cheers lower inflation, but a new risk has investors on edge The larger moves overnight, however, were in the U.S. dollar, which fell to a fresh two-month low of 103.478 against a basket of its global peers before steadying at 103.588, well below its 200-day moving average, as investors continue to discount any Federal Reserve rate hikes while pricing in cuts for as early as May. Investors will likely focus on language from the Fed's November policy decision, which held rates steady for a second consecutive month at between 5.25% and 5.5%, when minutes of the two-day meeting are released Wednesday, for indications as to how policymakers are viewing the central bank's rate path. A smattering of earnings over the next three days, including a third quarter update from Nvidia (NVDA) - Get Free Report after the close of trading on Tuesday, will also keep Wall Street focused ahead of Thursday's market holiday and the traditionally thin liquidity of Black Friday. Heading into the start of the trading day, futures contracts tied to the S&P 500 are indicating a modest 2 point dip while those linked to the Dow Jones Industrial Average are priced for a 31 point gain. The tech-focused Nasdaq, which is up 9.92% for the month, is set for a 2 point bump. In overseas markets, Europe's Stoxx 600 was little-changed in early Frankfurt trading, with drugmaker Bayer AG plunging 20% to a new multi-decade low following the cancellation of late-stage trials of its blood-thinning treatment. Overnight in Asia, Japan's Nikkei 225 touched a fresh 33-year intra-day high of 33,853.46 points before profit taking pushed the benchmark 0.59% lower in the session, while the region-wide MSCI ex-Japan index was marked 0.91% higher into the close of trading.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...

*Композитный*

Композитный подносок - это защитный элемент в рабочей обуви, предохраняющий ногу от удара силой в 200 Дж. Подноски из композитных материалов отличаются небольшим весом.via forma full 5 https://ift.tt/P0ITDCh Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3580096.html)

Композитный

Композитный подносок - это защитный элемент в рабочей обуви, предохраняющий ногу от удара силой в 200 Дж. Подноски из композитных материалов отличаются небольшим весом.via forma full 5 https://ift.tt/P0ITDCh Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Сухпаек - ИРП*

Боеспособность каждого отдельного бойца зависит от его морально-волевых качеств, навыков обращения с оружием и боевой техникой, а также физической подготовки.via forma full 5 https://ift.tt/mIw8gYk Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3584777.html)

Сухпаек - ИРП

Боеспособность каждого отдельного бойца зависит от его морально-волевых качеств, навыков обращения с оружием и боевой техникой, а также физической подготовки.via forma full 5 https://ift.tt/mIw8gYk Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Национальная*

Федеральная служба войск национальной гвардии Российской Федерации (Росгвардия) — федеральный орган исполнительной власти Российской Федерации, спецслужба...via forma full 5 https://ift.tt/MYxFaSg Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3581058.html)

Национальная

Федеральная служба войск национальной гвардии Российской Федерации (Росгвардия) — федеральный орган исполнительной власти Российской Федерации, спецслужба...via forma full 5 https://ift.tt/MYxFaSg Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Microsoft nabs Sam Altman to lead AI effort following OpenAI boardroom 'train wreck'*

Updated at 8:20 AM EST Microsoft (MSFT) - Get Free Report shares powered higher Monday after it said OpenAI founder Sam Altman would lead the tech giant's AI effort following a weekend of boardroom drama that threatened the future of the ChatGPT creator. Microsoft said Altman, as well as his close associate Greg Brockman, will lead a newly-created AI team within the group following the ouster of Altman, and the resignation of Brockman, from OpenAI late Friday. Several key OpenAI employees also threatened to quit the group, which is credited for firing the starting gun on this year's AI investment rush, after a poorly-articulated statement from the board added to the uncertainty tied to Altman's surprise departure. Microsoft CEO Satya Nadella, who lobbied for Altman's return to the helm of OpenAI in the chaotic aftermath of his ousting late Friday, said the tech giant would continue working closely with the ChatGPT creator and its new CEO, former Amazon (AMZN) - Get Free Report Twitch executive Emmett Shear, in the weeks and months ahead. first and last time i ever wear one of these pic.twitter.com/u3iKwyWj0a— Sam Altman (@sama) November 19, 2023 "We remain committed to our partnership with OpenAI and have confidence in our product roadmap, our ability to continue to innovate with everything we announced at Microsoft Ignite, and in continuing to support our customers and partners," Nadella wrote in a post on the X social media website. "We look forward to getting to know Emmett Shear and OAI's new leadership team and working with them. And we’re extremely excited to share the news that Sam Altman and Greg Brockman, together with colleagues, will be joining Microsoft to lead a new advanced AI research team," he added. "We look forward to moving quickly to provide them with the resources needed for their success." Microsoft shares were marked 0.9% higher in pre-market trading to indicate a Monday opening bell price of $373.15 each, a move that would value the Redmond, Washington-based group at around $2.8 trillion. "The train wreck situation at OpenAI created by a four-person board (excluding Altman and Brockman) might go down in tech history as the one of the biggest debacle decisions in the history of Silicon Valley," said Wedbush analyst Dan Ives. "If Microsoft lost Altman he could have gone to Amazon, Google, Apple, or a host of other tech companies craving to get the face of AI globally in their doors," he added. "Instead he is safely in Microsoft's HQ now leading the company key AI efforts which we expect many key scientists and developers to leave OpenAI and head directly to Microsoft." Microsoft stock has added more than $1 trillion to its market value so far this year, and alongside Nvidia (NVDA) - Get Free Report, has become one of the hottest tech names in the market, since unveiling a $10 billion investment in OpenAI, the maker of the AI-powered ChatGPT search engine tool, in early January. Microsoft's overall investment of $13 billion, which translates to an equity stake of around 49% in OpenAI, did not come with a board seat. OpenAI's value was last estimated at around $86 billion. The group has touted the potential of ChatGPT, a tool that uses human language to process instructions and which is being embedded in the tech group's also-ran search engine Bing, to close the gap on market leader Google, the eponymous lead product of parent company Alphabet (GOOGL) - Get Free Report. Investors are betting that AI adoption will help Microsoft -- which generated just $3.2 billion in search revenue last year -- challenge the market dominance of Google, which churned around $43 billion.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stocks/microsoft-surges-as-openai-founder-sam-altman-joins-to-lead-ai-effort)